Laura Renee Marks MD PhD
Infectious Disease
Intern, Barnes-Jewish Hospital
Join to View Full Profile
620 S Taylor Ave# DvSaint Louis, MO 63110
Phone+1 314-362-9098
Fax+1 314-362-9851
Dr. Marks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University in St. Louis School of MedicinePost-Doctoral Fellowship, 2019 - 2021- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2021
- Washington University/B-JH/SLCH ConsortiumFellowship, Infectious Disease, 2017 - 2019
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2015 - 2017
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2015
Certifications & Licensure
MO State Medical License 2017 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Determining the Feasibility of Outpatient Parenteral Antibiotic Therapy for Persons Who Inject Opioids Start of enrollment: 2022 Mar 16
Roles: Principal Investigator, Contact
- Feasibility and Acceptability of HCV Treatment in Pregnancy Start of enrollment: 2024 Feb 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Association of Postpartum Inpatient Consultation Compared With Outpatient Referral With Hepatitis C Virus Treatment Completion.Leah M McCrary, Zoë Leydh, Megan R Curtis, Jessica Elrod-Gallegos, Patrick Kojima
O&G Open. 2025-10-01 - Association Between Sex and Recent Pregnancy and Hepatitis C Virus Treatment in People With Opioid Use Disorder.Caroline B Cary, L Madeline McCrary, Laura R Marks, Jeannie C Kelly, Sarah M Hartz
O&G Open. 2025-08-01 - 1 citationsDevelopment of a metabolome-based respiratory infection prognostic during COVID-19 arrival.John I Robinson, Laura R Marks, Andrew L Hinton, Jane A O'Halloran, Charles W Goss
Mbio. 2025-01-08
Press Mentions
Program Improves Hepatitis C Treatment Access for New MomsSeptember 25th, 2025- Bedside Initiation Boosts Postpartum HCV TreatmentSeptember 22nd, 2025
- Postpartum Mothers More Likely to Be Cured of Hepatitis C with Bedside TreatmentSeptember 10th, 2025
- Join now to see all
Grant Support
- Evaluation of the prevalence of xylazine and etiology of xylazine related invasive infectionsWASHINGTON UNIVERSITY2025–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
